Company Filing History:
Years Active: 2007-2013
Title: Frank Dieterle: Innovator in Kidney Health and Biomarkers
Introduction
Frank Dieterle is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of kidney health and biomarker research. With a total of 3 patents, his work has advanced the understanding of glomerular alterations and damage in the kidney.
Latest Patents
Dieterle's latest patents include innovative methods for assessing kidney health. One of his key inventions is the use of β-2-microglobulin to evaluate glomerular alterations and damage in the kidney. This method provides a reliable way to measure kidney function and detect potential issues early. Another significant patent focuses on a biomarker for the farnesyl pathway, which offers methods to determine how certain compounds interfere with steroid metabolism. This invention introduces a novel biomarker derived from felinine, enhancing the understanding of metabolic processes.
Career Highlights
Throughout his career, Frank Dieterle has worked with prominent companies in the pharmaceutical industry. He has been associated with Hoffmann-La Roche Inc. and Novartis AG, where he contributed to various research initiatives. His expertise in kidney health and biomarkers has positioned him as a valuable asset in these organizations.
Collaborations
Dieterle has collaborated with notable professionals in his field, including Goetz Schlotterbeck and Hans Senn. These partnerships have fostered innovation and have led to advancements in kidney health research.
Conclusion
Frank Dieterle's contributions to the field of kidney health and biomarkers are noteworthy. His patents and collaborations reflect his commitment to advancing medical science. His work continues to impact the understanding of kidney function and disease.